← back to search
Riku Fagerlund
University of Helsinki
· FI
Area of research
Immunology · Infectious Diseases
Research interest
Research interests include interferon and immune responses, SARS-CoV-2 and COVID-19 Research, Cytokine Signaling Pathways and Interactions, and NF-κB Signaling Pathways.
h-index
16
citations
1,795
works
36
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways
Nature Immunology
2012
cited by
177
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Tony Yu
· Princess Margaret Cancer Centre
1
papers (2012–2012)
—
·
1
papers (2012–2012)
Jeffrey D. Kearns
· Novartis (China)
1
papers (2012–2012)
Alexander Hoffmann
· University of California, Los Angeles
1
papers (2012–2012)
Jenny Q Huang
· University of California, San Diego
1
papers (2012–2012)
Masataka Asagiri
· Yamaguchi University
1
papers (2012–2012)
Julia Ponomarenko
· Universitat Pompeu Fabra
1
papers (2012–2012)
Elina I. Zúñiga
· University of California San Diego
1
papers (2012–2012)
Jeremy Davis‐Turak
· Rosalind Franklin Institute
1
papers (2012–2012)
Mónica Macal
· University of California San Diego
1
papers (2012–2012)